I agree with U that market is looking for NPAT and cash burn out. Also re NEXSTLS growth and its continuous supply. As a thumb rule, MYX or for that matter a good pharma counter delivers 30% as NPAT of revenue. and then can get 3-7 times market cap of its revenue. Considering Astronomical gross margins of MYX it has the ability to deliver NPAT of 30% on revenue. Some thing missing some where and i hope they have set their clock right. Market needs a confirmation of that. IF AND WHEN THAT HAPPENS THEN AT 500 MILLIN REVENUE STOCK HAS FAIR MARKET PRICE IN THE RANGE OF 20-50 DOLLARS. Market probably knows more than what U AND ME KNOW or just looking for the confirmation on some of these issues that they are behind MYX..
MYX Price at posting:
$5.76 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)